09.03.21
Kaohsiung City, Taiwan
www.e-nonwoven.com.tw
2020 Nonwoven Sales: $348 million
Key Personnel
John Huang, EVP; Ryan Huang, VP, Jen-Tsung Huang, VP
Plants
Yanchao I and II (Taiwan), Pinghu (China), Ahmedabad (India)
Processes
Carded thermal bond, air-through bond, spunlace, meltblown,
Surging demand for personal protective equipment such as face masks, mask fabric, protective gowns and gown fabrics drove sales upward to $348 million at Nan Liu Enterprise. Early on in the Covid-19 pandemic, the company prioritized production of anti-pandemic related products. Production at the company’s plants in Yanchao, Taiwan, was centered on making these products while Nan Liu’s Pinghu site on mainland China focused on making the company’s core products and focusing on existing customers.
While business began to normalize in early 2021, infection surges in Taiwan continued into the second quarter increasing demand again for PPE.
In 2020, Nan Liu set up 50 protection mask lines (120 million masks/month) and a meltblown nonwoven production line in Yanchao Taiwan. Additionally market demand for spunlace nonwovens and air through nonwoven increased enormously and this also caused prices to increase.
“The market demand for face masks in Taiwan is approaching normalization right now,” says exports director Bernard Kerstens. “There is now a situation of oversupply in the markets for face masks and meltblown materials. The market demand will continue to exist, but we need to upgrade our products and production technology to transform from general medical masks to production of surgical masks and N95 and FFP2 masks. Meltblown cloth has also been transformed to produce HEPA and elastic cloth.”
The Yanchao, Taiwan, plant also houses a 6.2 meter spunlace line, a three-meter wide cotton spunlace line as well as assets for coating and producing medical masks and a cleanroom biotechnology building.
The spunlace line has benefitted from the demand for isolation gowns and protective gowns related to pandemic prevention products. While the company has no plan to add to its spunlace manufacturing footprint, it is upgrading another existing spunlace line to allow it to make industrial wipe and surgical gown fabrics. This investment is expected to be complete next year.
Meanwhile production in Pinghu, where Nan Liu has recently invested $43 million to add four air though bonding lines, remains strong as air through lines are operating.
www.e-nonwoven.com.tw
2020 Nonwoven Sales: $348 million
Key Personnel
John Huang, EVP; Ryan Huang, VP, Jen-Tsung Huang, VP
Plants
Yanchao I and II (Taiwan), Pinghu (China), Ahmedabad (India)
Processes
Carded thermal bond, air-through bond, spunlace, meltblown,
Surging demand for personal protective equipment such as face masks, mask fabric, protective gowns and gown fabrics drove sales upward to $348 million at Nan Liu Enterprise. Early on in the Covid-19 pandemic, the company prioritized production of anti-pandemic related products. Production at the company’s plants in Yanchao, Taiwan, was centered on making these products while Nan Liu’s Pinghu site on mainland China focused on making the company’s core products and focusing on existing customers.
While business began to normalize in early 2021, infection surges in Taiwan continued into the second quarter increasing demand again for PPE.
In 2020, Nan Liu set up 50 protection mask lines (120 million masks/month) and a meltblown nonwoven production line in Yanchao Taiwan. Additionally market demand for spunlace nonwovens and air through nonwoven increased enormously and this also caused prices to increase.
“The market demand for face masks in Taiwan is approaching normalization right now,” says exports director Bernard Kerstens. “There is now a situation of oversupply in the markets for face masks and meltblown materials. The market demand will continue to exist, but we need to upgrade our products and production technology to transform from general medical masks to production of surgical masks and N95 and FFP2 masks. Meltblown cloth has also been transformed to produce HEPA and elastic cloth.”
The Yanchao, Taiwan, plant also houses a 6.2 meter spunlace line, a three-meter wide cotton spunlace line as well as assets for coating and producing medical masks and a cleanroom biotechnology building.
The spunlace line has benefitted from the demand for isolation gowns and protective gowns related to pandemic prevention products. While the company has no plan to add to its spunlace manufacturing footprint, it is upgrading another existing spunlace line to allow it to make industrial wipe and surgical gown fabrics. This investment is expected to be complete next year.
Meanwhile production in Pinghu, where Nan Liu has recently invested $43 million to add four air though bonding lines, remains strong as air through lines are operating.